ClearPoint Neuro
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLPT and other ETFs, options, and stocks.About CLPT
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance.
CEOJoseph Michael Burnett
CEOJoseph Michael Burnett
Employees115
Employees115
HeadquartersSolana Beach, California
HeadquartersSolana Beach, California
Founded1998
Founded1998
Employees115
Employees115
CLPT Key Statistics
Market cap384.14M
Market cap384.14M
Price-Earnings ratio-16.93
Price-Earnings ratio-16.93
Dividend yield—
Dividend yield—
Average volume987.80K
Average volume987.80K
High today$14.63
High today$14.63
Low today$13.48
Low today$13.48
Open price$14.40
Open price$14.40
Volume676.73K
Volume676.73K
52 Week high$30.10
52 Week high$30.10
52 Week low$9.76
52 Week low$9.76
Stock Snapshot
With a market cap of 384.14M, ClearPoint Neuro(CLPT) trades at $13.51. The stock has a price-to-earnings ratio of -16.93.
During the trading session on 2025-11-20, ClearPoint Neuro(CLPT) shares reached a daily high of $14.63 and a low of $13.48. At a current price of $13.51, the stock is +0.2% higher than the low and still -7.7% under the high.
Trading volume for ClearPoint Neuro(CLPT) stock has reached 676.73K, versus its average volume of 987.8K.
Over the past 52 weeks, ClearPoint Neuro(CLPT) stock has traded between a high of $30.10 and a low of $9.76.
Over the past 52 weeks, ClearPoint Neuro(CLPT) stock has traded between a high of $30.10 and a low of $9.76.
People also own
Based on the portfolios of people who own CLPT. This list is generated using Robinhood data, and it’s not a recommendation.